De-Esterified Tragacanth Microspheres Loaded into Eudragit S-100 Coated Capsules for Colon-Targeted Delivery

Document Type : Research article

Authors

1 Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.

2 Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.

3 Nano Drug Delivery Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

4 Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Abstract

The objective of this study was to develop a novel bacterially-triggered micro-particular system of de-esterified tragacanth (DET) in combination with Eudragit S-100 coated capsules for colon drug delivery of 5-fluorouracil (5-FU) using microemulsion method. The loading study was conducted at different drug-to-polymer ratios and cross-linker concentrations. The maximum loading efficiency was achieved, 44.1% at 1:5 drug-to-polymer ratio and 0.7% cross-linker concentration. The FTIR results also confirmed the encapsulation of 5-FU in microspheres.
The release profile was dependent on the cross-linker concentration, environmental pH, and presence of pectinase enzyme. Microspheres inserted into Eudragit S-100 coated capsules released less than 5% of the drug at stomach and small intestine pH levels, whereas 70% of the drug was released at colon pH levels, and about 25% of the drug did not release unless in the presence of pectinase enzyme. To omit burst release, microspheres were washed with water, and the release became pH independent, and was just achieved in the presence of pectinase enzyme. 5-FU loaded microspheres with an IC50 value of 80 µg/mL were as effective as the free drug on HT-29. Generally, the results demonstrated that drug-loaded microspheres inserted into Eudragit S-100 coated capsules can be effective for colon-targeted delivery.
 
 

Keywords

Main Subjects

References

Shike M, Winawer S, Greenwald P, Bloch A, Hill
MJ and Swaroop S. Primary prevention of colorectal
cancer. The WHO Collaborating Centre for the
prevention of colorectal cancer. Bull. World Health
Organ. (1990) 68: 377.
Krishnaiah YS and Khan MA. Strategies of targeting
oral drug delivery systems to the colon and their
potential use for the treatment of colorectal cancer.
Pharm. Dev. Technol . (2012) 17: 521-40.
Chourasia M and Jain S. Pharmaceutical approaches
to colon targeted drug delivery systems . J. Pharm.
Pharm. Sci. (2003) 6: 33-66.
Sinha V and Kumria R. Polysaccharides in colon-
specific drug delivery. Int. J. Pharm. (2001) 224: 19-
38.
Acartürk F andTakka S. Calcium alginate microparticles
for oral administration: II. effect of formulation factors
on drug release and drug entrapment efficiency. J.
Microencapsul. (1999) 16: 291-301.
Pandey S, Mishra A, Raval P, Patel H, Gupta A and
Shah D. Chitosan-pectin polyelectrolyte complex as
a carrier for colon targeted drug delivery. J. Young.
Pharm. (2013) 5: 160-6.
Fattahi A, Petrini P, Munarin F, Shokoohinia Y, Golozar
MA, Varshosaz J and Tanzi MC. Polysaccharides
derived from tragacanth as biocompatible polymers
and gels. J. Appl. Polym. Sci . (2013) 129: 2092-102.
Shukla RK and Tiwari A. Carbohydrate polymers:
Applications and recent advances in delivering drugs
to the colon. Carbohyd. Polym . (2012) 88: 399-416.
Hoare TR and Kohane DS. Hydrogels in drug delivery:
Progress and challenges. Polym. (2008) 49: 1993-2007.
Hsu FY, Yu DS and Huang CC. Development of pH-
sensitive pectinate/alginate microspheres for colon
drug delivery. J. Mater. Sci. Mater. Med. (2013) 24:
317-23.
Paharia A, Yadav AK, Rai G, Jain SK, Pancholi SS and
Agrawal GP. Eudragit-coated pectin microspheres of

5-fluorouracil for colon targeting. AAPS. Pharm. Sci.
Tech. (2007) 8: E87-E93.
Yan S, Zhu J, Wang Z, Yin J, Zheng Y and Chen X.
Layer-by-layer assembly of poly (L-glutamic acid)/
chitosan microcapsules for high loading and sustained
release of 5-fluorouracil. Eur. J. Pharm. Biopharm.
(2011) 78: 336-45.
Sancin P, Caputo O, Cavallari C, Passerini N,
Rodriguez L, Cini M and Fini A. Effects of ultrasound-
assisted compaction on Ketoprofen/Eudragit® S100
Mixtures. Eur. J. Pharm. Sci . (1999) 7: 207-13.
Jain D, Panda AK and Majumdar DK. Eudragit S100
entrapped insulin microspheres for oral delivery. AAPS
PharmSciTech. (2005) 6: E100-E107.
Yoo JW, Giri N and Lee CH. pH-sensitive Eudragit
nanoparticles for mucosal drug delivery. Int. J. Pharm.
(2011) 403: 262-7.
Lei L, Liu X, Guo S, Tang M, Cheng L and Tian L.
5-Fluorouracil-loaded multilayered films for drug
controlled releasing stent application: Drug release,
microstructure, and ex-vivo permeation behaviors. J.
Control. Releas. (2010) 146: 45-53.
Liu L, Fishman ML, Kost J and Hicks KB. Pectin-
based systems for colon-specific drug delivery via oral
route. Biomaterials (2003) 24: 3333-43.
Chourasia M and Jain S. Polysaccharides for colon
targeted drug delivery. Drug Deliv. (2004) 11: 129-48.
Singh B, Sharma N and Chauhan N. Synthesis,
characterization and swelling studies of pH responsive
psyllium and methacrylamide based hydrogels for the
use in colon specific drug delivery. Carbohyd. Polym.
(2007) 69: 631-43.
Sinha V and Kumria R. Microbially triggered drug
delivery to the colon. Eur. J. Pharm. Sci . (2003) 18:
3-18.
Nobbmann U, Connah M, Fish B, Varley P, Gee C,
Mulot S, Chen J, Zhou L, Lu Y and Sheng F. Dynamic
light scattering as a relative tool for assessing the
molecular integrity and stability of monoclonal
antibodies. Biotechnol. Genet. Eng. Rev. (2007) 24:
117-28.
Ramasamy T, Ruttala HB, Shanmugam S and Umadevi
SK. Eudragit-coated aceclofenac-loaded pectin
microspheres in chronopharmacological treatment of
rheumatoid arthritis. Drug Deliv. (2013) 20: 65-77.
Rai G, Yadav AK, Jain NK and Agrawal GP. Eudragit-
coated dextran microspheres of 5-fluorouracil for site-
specific delivery to colon. Drug Deliv. (2016) 23: 328-
37.

Iranian Journal of Pharmaceutical Research
Volume 17, Issue 2
Spring 2018
Pages 470-479

Files

Share

How to cite

Statistics